Atsuo Takashima

Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With <i>RAS</i> Wild-type, Left-Sided Metastatic Colorectal Cancer

Jun Watanabe, Kei Muro, Kohei Shitara et al. · JAMA · 2023 · 258 citations · Full text

Medicine, Oncology, Pharmacology +17

Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial

Kohei Shitara, Atsuo Takashima, Kazumasa Fujitani et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 219 citations

Medicine, Oncology, Pharmacology +7

Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors

Fusako Waki, Masashi Ando, Atsuo Takashima et al. · Journal of Neuro-Oncology · 2008 · 146 citations

Medicine, Neurosurgery, Oncology +17

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

Ken Masuda, Hirokazu Shoji, Kengo Nagashima et al. · BMC Cancer · 2019 · 140 citations · Full text

Life Sciences, Immunology, Oncology +16

Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial

Kanwal Raghav, Salvatore Siena, Atsuo Takashima et al. · The Lancet Oncology · 2024 · 126 citations

Medicine, Oncology, Pharmacology +13